Results 191 to 200 of about 178,848,266 (217)
Some of the next articles are maybe not open access.
Medication-Related Osteonecrosis of the Jaws in the Pediatric Population
Journal of Oral and Maxillofacial Surgery, 2022Few reports have investigated medication-related osteonecrosis of the jaws (MRONJ) in the pediatric population. The study purpose was to measure the frequency of MRONJ in pediatric patients receiving antiresorptive medications at our institution.This retrospective case series was granted an exemption by the University of Texas Southwestern Medical ...
Timothy W. Neal, Thomas Schlieve
openaire +2 more sources
Teriparatide for the Treatment of Medication-Related Osteonecrosis of the Jaw
American Journal of Therapeutics, 2020Medication-related osteonecrosis of the jaw (MRONJ) is a painful and intractable disease of the jaw that clinically presents as an area of ulceration with exposed necrotic bone. In severe cases, it can predispose to jaw fracture, skin fistula, or osteolysis extending beyond the region of the alveolar bone.
Kirti, Chopra, Namrita, Malhan
openaire +2 more sources
Pain characteristics in medication-related osteonecrosis of the jaws
Supportive Care in Cancer, 2020To characterise pain from medication-related osteonecrosis of the jaws (MRONJ) and the effects of antimicrobial treatment on it.Data from files of patients diagnosed with MRONJ according to the position paper of the American Association of Oral and Maxillofacial Surgeons (2014) and Multinational Association of Supportive Care in Cancer and American ...
Yaron, Haviv +5 more
openaire +2 more sources
Medication-Related Osteonecrosis of the Jaw
2022Journal of The Dental Association of Thailand, 72, 2, 204 ...
openaire +1 more source
Bisphosphonate and Medication-Related Osteonecrosis of the Jaw: A Review
Seminars in Musculoskeletal Radiology, 2016For patients with malignant disease taking bisphosphonates and denosumab, the incidence of medication-related osteonecrosis of the jaw (MRONJ) is up to 15% in contrast to 0.01% in patients with osteoporosis. Clinical presentation of MRONJ extends from asymptomatic exposure of bone in 94% of patients to severe cases of mandibular fractures in a minority
Thomas, Mücke +4 more
openaire +2 more sources
Medication-Related Osteonecrosis of Jaws
This chapter discusses the common types of medications associated with medication-related osteonecrosis of jaw (MRONJ) including bisphosphates, monoclonal antibodies and anti-angiogenic agents. Risk assessment of patients, pre-treatment prevention and management principles of MRONJ in general dental practice settings are outlined.Luiz Alcino Monteiro Gueiros +5 more
openaire +3 more sources
Medication-related osteonecrosis of the jaw: An institution’s experience
CRANIO®, 2018This study aimed to evaluate and report the outcomes associated with the management of patients who were treated surgically for medication-related osteonecrosis of the jaw (MRONJ).Methods: Demographic and medical profiles of patients with a diagnosis of MRONJ were created.
Mehmet Ali Altay +6 more
openaire +2 more sources
Medication-related osteonecrosis of the jaw: A literature review and update
Genesis, 2022Shinichiro Kuroshima +2 more
exaly
Medication-Related Osteonecrosis of the Jaw: A Critical Narrative Review
Journal of Clinical Medicine, 2021Oscar Alvarez-Calderon +2 more
exaly